TMEM202 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:338949, HGNC:33733, NM_001080462, NP_001073931, NR_148418, NR_148419, TMEM202, XM_011521497, XM_011521499, XM_024449910, XP_011519799, XP_011519801, XP_024305678, transmembrane protein 202

Id:ENSG00000187806

Entrez:338949

Ensembl:ENSG00000187806

Description:transmembrane protein 202

Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TMEM202's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TMEM202.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TMEM202.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TMEM202.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TMEM202.

Results found

Linked to

	Label	Description
	GSE181517 2 V 1 DOXORUBICIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE120336 0 V 3 TAMOXIFEN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE218098 GSE218099 TCF19 knockdown RNA Small Interfering 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE160083,GSE160084 1 V 0 TAMOXIFEN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE101239 3 V 2 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE206779 1 V 3 ANGIOTENSIN II MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 0 V 1 DOXORUBICIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE62843,GSE64370 0 V 3 FURAN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE250534 0 V 3 CABERGOLINE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

GSE181517 2 V 1 DOXORUBICIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE120336 0 V 3 TAMOXIFEN MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE218098 GSE218099 TCF19 knockdown RNA Small Interfering 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE160083,GSE160084 1 V 0 TAMOXIFEN MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE101239 3 V 2 VALPROIC ACID MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE206779 1 V 3 ANGIOTENSIN II MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE181517 0 V 1 DOXORUBICIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE62843,GSE64370 0 V 3 FURAN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE250534 0 V 3 CABERGOLINE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.